Document Detail


Adapalene gel 0.1% in the treatment of infantile acne: an open clinical study.
MedLine Citation:
PMID:  18577052     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Infantile acne is an uncommon condition in pediatric age. We determined the efficacy and safety of adapalene gel 0.1% in the treatment of infantile acne. Twelve patients were enrolled for adapalene gel 0.1% application once daily over a 16-week treatment period. Efficacy evaluation included counting the inflammatory and noninflammatory lesions by the physician and global evaluation of the improvement. After 16 weeks all patients were followed up for a 1-year period. The time of clearance of the infantile acne lesions was 3 months in four (33%) patients and 4 months in eight (67%) patients (median 3.4 months). Adapalene gel produced reductions in noninflammatory and inflammatory lesions counts. Limited side effects were observed and none of them required stopping the therapy. No patient was left with scarring. Three patients were showed mild lesions in the 1-year follow-up period. Adapalene gel 0.1% was found to be a highly effective and safe drug in the treatment of mild-to-moderate infantile acne.
Authors:
Osman Kose; Erol Koç; Ercan Arca
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Pediatric dermatology     Volume:  25     ISSN:  1525-1470     ISO Abbreviation:  Pediatr Dermatol     Publication Date:    2008 May-Jun
Date Detail:
Created Date:  2008-06-25     Completed Date:  2008-08-28     Revised Date:  2013-05-24    
Medline Journal Info:
Nlm Unique ID:  8406799     Medline TA:  Pediatr Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  383-6     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Gülhane Military Medical Academy, School of Medicine Etlik, Ankara, Turkey. okose@gata.edu.tr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acne Vulgaris / drug therapy*,  pathology
Administration, Cutaneous
Analysis of Variance
Child, Preschool
Dermatologic Agents / adverse effects,  therapeutic use*
Erythema / chemically induced
Face / pathology
Female
Gels
Humans
Infant
Male
Naphthalenes / adverse effects,  therapeutic use*
Pain / chemically induced
Pruritus / chemically induced
Skin / pathology
Statistics, Nonparametric
Treatment Outcome
Chemical
Reg. No./Substance:
0/Dermatologic Agents; 0/Gels; 0/Naphthalenes; 1L4806J2QF/adapalene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Richner-Hanhart syndrome detected by expanded newborn screening.
Next Document:  Successful treatment of florid cutaneous warts with intravenous cidofovir in an 11-year-old girl.